Table 5.
Metabolic syndrome components | IDF Proportion (95% CI) | ATP III Proportion (95% CI) | AACE Proportion (95% CI) |
---|---|---|---|
In males | |||
IFG | 38.62 (36.49-40.76) | 38.62 (36.49-40.76 | 21.98 (20.10-23.87) |
Low HDL-C | 54.42 (52.25-56.59) | 54.42 (52.25-56.59) | 54.00 (51.83-56.17) |
High TG | 53.26 (51.03-55.50) | 53.26 (51.03-55.50) | 53.26 (51.03-55.50) |
HTN | 47.81 (45.25-50.37) | 47.81 (45.25-50.37) | 47.81 (45.25-50.37) |
Obesity | 72.68 (70.54-74.83) | 36.83 (34.55-39.11) | - |
High risk of insulin resistance or BMI ≥25 kg/m2 or waist circumference ≥102 cm (men) or ≥88 cm (women) | - | - | 68.93 (66.84-71.02) |
In females | |||
IFG | 44.01 (42.00-46.03) | 44.01 (42.00-46.03) | 25.13 (23.50-26.76) |
Low HDL | 66.69 (64.90-68.48) | 66.69 (64.90-68.48) | 66.10 (64.32-67.88) |
High TG | 52.70 (50.95-54.44) | 52.70 (50.95-54.44) | 52.26 (50.50-54.03) |
HTN | 44.69 (42.84-46.52) | 44.69 (42.84-46.52) | 44.69 (42.84-46.52) |
Obesity | 98.78 (98.38-99.18) | 92.81 (91.76-93.87) | - |
High risk of insulin resistance or BMI ≥25 kg/m2 or waist circumference ≥102 cm (men) or ≥88 cm (women) | - | - | 94.76 (93.90-95.61) |
Total | |||
IFG | 41.81 (40.32-43.29) | 41.81 (40.32-43.29) | 23.84 (22.63-25.05) |
Low HDL | 61.67 (60.22-63.11) | 61.67 (60.22-63.11) | 61.14 (59.71-62.57) |
High TG | 52.93 (51.52-54.34) | 52.93 (51.52-54.34) | 52.67 (51.25-54.10) |
HTN | 45.97 (44.38-47.56) | 45.97 (44.38-47.56) | 45.97 (44.38-47.56) |
Obesity | 92.81 (87.07-89.03) | 69.80 (68.43-71.16) | - |
High risk of insulin resistance or BMI ≥25 kg/m2 or waist circumference ≥102 cm (men) or ≥88 cm (women) | - | - | 84.14 (83.09-85.18) |
CI=Confidence interval; IFG=Impaired fasting glucose; HDL-C=High-density lipoprotein-cholesterol; BMI=Body mass index; ATP III=Adult Treatment Panel III; IDF=International Diabetes Federation; AACE=American Association of Clinical Endocrinologists; TG=Triglyceride; HTN=Hypertension